This week Mad in America examines studies related to adverse events associated with antipsychotics and antidepressants, ...

Bayer presents positive data on asundexian, which shows superior efficacy with no added bleeding risk, boosting hopes for regulatory approval.

For two days, the patient lived as a human being with no lungs, stabilized by a machine that breathed and buffered his ...

ClearPoint Neuro is positioned for robust growth in 2026, driven by IRRAS, the PRISM 1.5T system clearance, and the company's new CRO facility. While the immediate future of uniQure's AMT-130 remains ...

Byfield is one of over 100,000 people waiting for a life-saving organ transplant in the country.

Analysis of hospital registry data found that people who were hospitalized due to bleeding in the brain and who had taken multiple antiplatelet medications, or medications stronger than aspirin, were ...

Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

American Stroke Association International Stroke Conference 2026 annual awards go to 11 stroke researchers for science, brain health contributions.

Timothy Fernandes, MD, MPH Director, Comprehensive Pulmonary Embolism Care Professor of Medicine UC San Diego Health San ...